Related Experiment Video
Updated: Jan 10, 2026

Delivery of Antibodies into the Murine Brain via Convection-enhanced Delivery
Published on: July 18, 2019
"Will I Be Able to Get a Cremation?" A Concern of a Cancer Patient With an Intrathecal Drug Delivery System
Benedict Moran1, Anna Grosse1, Rebecca Speltz Paiz1
1Department of Anesthesiology, University of Minnesota, Minneapolis, MN.
Background:
Intrathecal drug delivery systems (IDDS) may pose additional restrictions on terminal cancer patients in their end-of-life planning. The patient provided HIPAA compliant consent for the inclusion of their clinical information in this report.
Case Report:
A 62-year-old male with recurrent metastatic spindle cell carcinoma to the ribs and thoracolumbar junction with vertebral compression fracture had an IDDS implanted to manage cancer-related pain. The patient had approached a funeral home to plan his last rites with a preference for cremation. However, the funeral home advised the patient that special precautions were not required for cremation with an IDDS.
Conclusion:
The medical device disposal process can be improved through formal communication between the medical team members and the funeral home directors. Device disposal education can ensure safe disposal and prevent cremation-related adverse events.
Related Concept Videos
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...

